{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:55:14Z","timestamp":1794264914295,"version":"4.9.0"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Fibrous dysplasia\/McCune Albright syndrome (FD\/MAS) is a rare genetic disease caused by postzygotic activating variants in the <jats:italic>GNAS<\/jats:italic> gene, encoding the \u03b1 subunit of stimulatory G protein (G\u03b1<jats:sub>s<\/jats:sub>). Although multiple organs may be involved, skeletal lesions usually represent the most severe and least treatable expression of the disease, leading to bone deformities, spontaneous fractures, and chronic pain that severely reduce patients\u2019 quality of life.<\/jats:p>\n          <jats:p>The recognition of the causative G\u03b1<jats:sub>s<\/jats:sub> variants and the consequent ligand-independent activation of the adenylyl cyclase\/cAMP\/PKA pathway has provided a clear molecular explanation to most extra-skeletal pathologies of FD\/MAS, leading to the development of effective therapeutic approaches. In contrast, a detailed understanding of the cellular and molecular mechanisms that act downstream of the G\u03b1<jats:sub>s<\/jats:sub> pathway to generate FD bone lesions and clinical expression thereof remain elusive. Multiple key issues remain to be addressed, including some questions that have recently emerged such as the interaction between mutated and non-mutated cells and the role of the latter in the development of the fibrotic tissue.<\/jats:p>\n          <jats:p>In this review, we provide a summary of the proof-of-concept, preclinical data, and experimental tools that have emerged to date from basic and translational studies on FD and represent the background for future research on the pathogenesis and treatment of this rare disease.<\/jats:p>","DOI":"10.1186\/s13023-025-03909-8","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T13:45:34Z","timestamp":1754660734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Fibrous dysplasia\/McCune-Albright syndrome: state-of-the-art advances, pathogenesis, and basic\/translational research"],"prefix":"10.1186","volume":"20","author":[{"given":"Biagio","family":"Palmisano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camryn","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Boyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia F.","family":"Charles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Corsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando A.","family":"Fierro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Heegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"van der Heijden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles S.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaymin","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Wehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly L.","family":"Wentworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward C.","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Riminucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"3909_CR1","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1359\/jbmr.2000.15.1.120","volume":"15","author":"P Bianco","year":"2000","unstructured":"Bianco P, Riminucci M, Majolagbe A, Kuznetsov SA, Collins MT, Mankani MH, et al. Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone. J Bone Min Res. 2000;15:120\u20138.","journal-title":"J Bone Min Res"},{"key":"3909_CR2","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1365-2559.2007.02676.x","volume":"50","author":"BD Idowu","year":"2007","unstructured":"Idowu BD, Al-Adnani M, O\u2019Donnell P, Yu L, Odell E, Diss T, et al. A sensitive mutation\u2010specific screening technique for GNAS1 mutations in cases of fibrous dysplasia: the first report of a codon 227 mutation in bone. Histopathology. 2007;50:691\u2013704.","journal-title":"Histopathology"},{"key":"3909_CR3","first-page":"750","volume":"79","author":"A Shenker","year":"1994","unstructured":"Shenker A, Weinstein LS, Sweet DE, Spiegel AM. An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome. J Clin Endocrinol Metab. 1994;79:750\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"3909_CR4","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1056\/NEJM199112123252403","volume":"325","author":"LS Weinstein","year":"1991","unstructured":"Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the McCune\u2013Albright syndrome. N Engl J Med. 1991;325:1688\u201395.","journal-title":"N Engl J Med"},{"key":"3909_CR5","doi-asserted-by":"crossref","unstructured":"Schwindinger WF, Francomano CA, Levine MA. Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci. 1992;89:5152\u20136.","DOI":"10.1073\/pnas.89.11.5152"},{"key":"3909_CR6","first-page":"1624","volume":"83","author":"A Lania","year":"1998","unstructured":"Lania A, Persani L, Ballar\u00e9 E, Mantovani S, Losa M, Spada A. Constitutively active Gs\u03b1 is associated with an increased phosphodiesterase activity in human growth Hormone-Secreting Adenomas1. J Clin Endocrinol Metab. 1998;83:1624\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"3909_CR7","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.cell.2018.03.018","volume":"173","author":"Q Hu","year":"2018","unstructured":"Hu Q, Shokat KM. Disease-Causing mutations in the G protein G\u03b1s subvert the roles of GDP and GTP. Cell. 2018;173:1254\u2013e126411.","journal-title":"Cell"},{"key":"3909_CR8","unstructured":"Szymczuk V, Florenzano P, de Castro LF, Collins MT, Boyce AM. Fibrous Dysplasia \/ McCune-Albright Syndrome. 1993."},{"key":"3909_CR9","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJM193704292161701","volume":"216","author":"ALBRIGHTF BUTLER","year":"1937","unstructured":"Albright F, Butler AM, Hampton AO, Smith P. Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction, with precocious puberty in females. N Engl J Med. 1937;216:727\u201346.","journal-title":"N Engl J Med"},{"key":"3909_CR10","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0022-3476(05)80943-6","volume":"123","author":"A Shenker","year":"1993","unstructured":"Shenker A, Weinstein LS, Moran A, Pescovitz OH, Charest NJ, Boney CM, et al. Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein Gs. J Pediatr. 1993;123:509\u201318.","journal-title":"J Pediatr"},{"key":"3909_CR11","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1172\/JCI2361","volume":"101","author":"P Bianco","year":"1998","unstructured":"Bianco P, Kuznetsov SA, Riminucci M, Fisher LW, Spiegel AM, Robey PG. Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gsalpha-mutated skeletal progenitor cells. J Clin Invest. 1998;101:1737\u201344.","journal-title":"J Clin Invest"},{"key":"3909_CR12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1399-0004.1986.tb01261.x","volume":"29","author":"R Happle","year":"1986","unstructured":"Happle R. The McCune-Albright syndrome: a lethal gene surviving by mosaicism. Clin Genet. 1986;29:321\u20134.","journal-title":"Clin Genet"},{"key":"3909_CR13","doi-asserted-by":"crossref","unstructured":"Khan SK, Yadav PS, Elliott G, Hu DZ, Xu R, Yang Y, Induced. Gnas R201H expression from the endogenous Gnas locus causes fibrous dysplasia by up-regulating Wnt\/\u03b2-catenin signaling. Proceedings of the National Academy of Sciences. 2018;115.","DOI":"10.1073\/pnas.1714313114"},{"key":"3909_CR14","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1002\/jbmr.2267","volume":"29","author":"I Saggio","year":"2014","unstructured":"Saggio I, Remoli C, Spica E, Cersosimo S, Sacchetti B, Robey PG, et al. Constitutive expression of Gs\u03b1(R201C) in mice produces a heritable, direct replica of human fibrous dysplasia bone pathology and demonstrates its natural history. J Bone Min Res. 2014;29:2357\u201368.","journal-title":"J Bone Min Res"},{"key":"3909_CR15","doi-asserted-by":"crossref","unstructured":"Riminucci M, Saggio I, Gehron Robey P, Bianco P. Fibrous dysplasia as a stem cell disease. J Bone Miner Res. 2006;21.","DOI":"10.1359\/jbmr.06s224"},{"key":"3909_CR16","doi-asserted-by":"crossref","unstructured":"Palmisano B, Labella R, Donsante S, Remoli C, Spica E, Coletta I et al. Gs\u03b1R201C and estrogen reveal different subsets of bone marrow adiponectin expressing osteogenic cells. Bone Res. 2022;10:50. Available from: https:\/\/www.nature.com\/articles\/s41413-022-00220-1","DOI":"10.1038\/s41413-022-00220-1"},{"key":"3909_CR17","first-page":"472","volume-title":"Soft tissue and bone tumours. Fibrous dysplasia WHO classification of tumours, soft tissue and bone tumours","author":"G Siegal","year":"2020","unstructured":"Siegal G, Bloem J, Cates J, Hameed M. Soft tissue and bone tumours. Fibrous dysplasia WHO classification of tumours, soft tissue and bone tumours. 5th ed. Lyon: IARC; 2020. pp. 472\u20133.","edition":"5"},{"key":"3909_CR18","first-page":"155","volume":"12","author":"E Ippolito","year":"2003","unstructured":"Ippolito E, Bray EW, Corsi A, De Maio F, Exner UG, Robey PG, et al. Natural history and treatment of fibrous dysplasia of bone: a multicenter clinicopathologic study promoted by the European pediatric orthopaedic society. J Pediatr Orthop B. 2003;12:155\u201377.","journal-title":"J Pediatr Orthop B"},{"key":"3909_CR19","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1359\/jbmr.2003.18.7.1235","volume":"18","author":"A Corsi","year":"2003","unstructured":"Corsi A, Collins MT, Riminucci M, Howell PG, Boyde A, Robey PG, et al. Osteomalacic and hyperparathyroid changes in fibrous dysplasia of bone: core biopsy studies and clinical correlations. J Bone Miner Res. 2003;18:1235\u201346.","journal-title":"J Bone Miner Res"},{"key":"3909_CR20","doi-asserted-by":"publisher","unstructured":"Collins MT, Boyce AM, Riminucci M et al. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Bilezikian JP, Bouillon R, Clemens T, Compston J, Bauer DC, Ebeling PR, editors. In Bilezikian JP, editor Primer of Metabolic bone diseases 9th ed. Wiley; 2018. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/book\/https:\/\/doi.org\/10.1002\/9781119266594","DOI":"10.1002\/9781119266594"},{"key":"3909_CR21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/(SICI)1096-9896(199901)187:2<249::AID-PATH222>3.0.CO;2-J","volume":"187","author":"M Riminucci","year":"1999","unstructured":"Riminucci M, Liu B, Corsi A, Shenker A, Spiegel AM, Robey PG, et al. The histopathology of fibrous dysplasia of bone in patients with activating mutations of the gs?? Gene: site-specific patterns and recurrent histological hallmarks. J Pathol. 1999;187:249\u201358.","journal-title":"J Pathol"},{"key":"3909_CR22","doi-asserted-by":"crossref","unstructured":"Jones SJ, Boyde A. The organization and gross mineralization patterns of the collagen fibres in sharpey fibre bone. Cell Tissue Res. 1974;148.","DOI":"10.1007\/BF00224320"},{"key":"3909_CR23","doi-asserted-by":"publisher","first-page":"100524","DOI":"10.1016\/j.coemr.2024.100524","volume":"35","author":"B Palmisano","year":"2024","unstructured":"Palmisano B, Corsi A, Riminucci M. Adiponectin expressing skeletal stem\/progenitor cells in the bone and bone marrow homeostasis. Curr Opin Endocr Metab Res. 2024;35:100524.","journal-title":"Curr Opin Endocr Metab Res"},{"key":"3909_CR24","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.radcr.2023.01.074","volume":"18","author":"A Alshalan","year":"2023","unstructured":"Alshalan A, Asiri Y, AlGarni A, Tayara B. Fibrocartilaginous dysplasia: what do we know so far? Radiol Case Rep. 2023;18:1763\u20136.","journal-title":"Radiol Case Rep"},{"key":"3909_CR25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.13107\/jocr.2022.v12.i02.2668","volume":"12","author":"A Lakshmanan","year":"2022","unstructured":"Lakshmanan A, Parameswaran A. Fibrocartilaginous Dysplasia\u2013 A report of five cases with review of literature. J Orthop Case Rep. 2022;12:61\u20134.","journal-title":"J Orthop Case Rep"},{"key":"3909_CR26","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1359\/jbmr.060818","volume":"21","author":"A Corsi","year":"2006","unstructured":"Corsi A, De Maio F, Ippolito E, Cherman N, Robey PG, Riminucci M, et al. Clinical vignette: monostotic fibrous dysplasia of the proximal femur and liposclerosing myxofibrous tumor: which one is which? J Bone Miner Res. 2006;21:1955\u20138.","journal-title":"J Bone Miner Res"},{"key":"3909_CR27","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/modpathol.2012.223","volume":"26","author":"F Tabareau-Delalande","year":"2013","unstructured":"Tabareau-Delalande F, Collin C, Gomez-Brouchet A, Decouvelaere A-V, Bouvier C, Larousserie F, et al. Diagnostic value of investigating GNAS mutations in fibro-osseous lesions: a retrospective study of 91 cases of fibrous dysplasia and 40 other fibro-osseous lesions. Mod Pathol. 2013;26:911\u201321.","journal-title":"Mod Pathol"},{"key":"3909_CR28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bjoms.2019.09.006","volume":"58","author":"A Corsi","year":"2020","unstructured":"Corsi A, Fadda MT, Terenzi V, Valentini V, Riminucci M. Secondary desmoplastic fibroma-like tissue changes in mandibular fibrous dysplasia: clinicopathological and molecular study of a case. Br J Oral Maxillofac Surg. 2020;58:96\u20138.","journal-title":"Br J Oral Maxillofac Surg"},{"key":"3909_CR29","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1002\/jbmr.3828","volume":"34","author":"B Palmisano","year":"2019","unstructured":"Palmisano B, Spica E, Remoli C, Labella R, Di Filippo A, Donsante S, et al. RANKL Inhibition in fibrous dysplasia of bone: A preclinical study in a mouse model of the human disease. J Bone Miner Res. 2019;34:2171\u201382.","journal-title":"J Bone Miner Res"},{"key":"3909_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41413-023-00311-7","volume":"12","author":"LF de Castro","year":"2024","unstructured":"de Castro LF, Whitlock JM, Michel Z, Pan K, Taylor J, Szymczuk V, et al. RANKL Inhibition reduces lesional cellularity and G\u03b1s variant expression and enables osteogenic maturation in fibrous dysplasia. Bone Res. 2024;12:10.","journal-title":"Bone Res"},{"key":"3909_CR31","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1056\/NEJMc2214862","volume":"388","author":"LF de Castro","year":"2023","unstructured":"de Castro LF, Michel Z, Pan K, Taylor J, Szymczuk V, Paravastu S, et al. Safety and efficacy of denosumab for fibrous dysplasia of bone. N Engl J Med. 2023;388:766\u20138.","journal-title":"N Engl J Med"},{"key":"3909_CR32","doi-asserted-by":"publisher","first-page":"117047","DOI":"10.1016\/j.bone.2024.117047","volume":"181","author":"B Palmisano","year":"2024","unstructured":"Palmisano B, Farinacci G, Campolo F, Tavanti C, Stefano A, Donsante S, et al. A pathogenic role for brain-derived neurotrophic factor (BDNF) in fibrous dysplasia of bone. Bone. 2024;181:117047.","journal-title":"Bone"},{"key":"3909_CR33","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00223-020-00752-w","volume":"107","author":"A Corsi","year":"2020","unstructured":"Corsi A, Palmisano B, Spica E, Di Filippo A, Coletta I, Dello Spedale Venti M, et al. Zoledronic acid in a mouse model of human fibrous dysplasia: ineffectiveness on tissue pathology, formation of \u2018giant osteoclasts\u2019 and pathogenetic implications. Calcif Tissue Int. 2020;107:603\u201310.","journal-title":"Calcif Tissue Int"},{"key":"3909_CR34","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1001\/archsurg.1938.01190230153012","volume":"36","author":"LICHTENSTEINL POLYOSTOTIC","year":"1938","unstructured":"Lichtenstein L. Polyostotic fibrous dysplasia. Arch Surg. 1938;36:874.","journal-title":"Arch Surg"},{"key":"3909_CR35","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/00007890-197404000-00001","volume":"17","author":"AJ Friedenstein","year":"1974","unstructured":"Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Transplantation. 1974;17:331\u201340.","journal-title":"Transplantation"},{"key":"3909_CR36","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1242\/dev.102210","volume":"142","author":"P Bianco","year":"2015","unstructured":"Bianco P, Robey PG. Skeletal stem cells. Development. 2015;142:1023\u20137.","journal-title":"Development"},{"key":"3909_CR37","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.3390\/ijms22083989","volume":"22","author":"S Donsante","year":"2021","unstructured":"Donsante S, Palmisano B, Serafini M, Robey PG, Corsi A, Riminucci M. From stem cells to Bone-Forming cells. Int J Mol Sci. 2021;22:3989.","journal-title":"Int J Mol Sci"},{"key":"3909_CR38","doi-asserted-by":"publisher","first-page":"4954","DOI":"10.3390\/ijms25094954","volume":"25","author":"H-Y Kim","year":"2024","unstructured":"Kim H-Y, Shim J-H, Kim B-K, Heo C-Y. Vitamin D attenuates fibrotic properties of fibrous Dysplasia-Derived cells for the transit towards osteocytic phenotype. Int J Mol Sci. 2024;25:4954.","journal-title":"Int J Mol Sci"},{"key":"3909_CR39","doi-asserted-by":"publisher","first-page":"774","DOI":"10.3390\/cells13090774","volume":"13","author":"Z Michel","year":"2024","unstructured":"Michel Z, Raborn LN, Spencer T, Pan KS, Martin D, Roszko KL, et al. Transcriptomic signature and Pro-Osteoclastic secreted factors of abnormal Bone-Marrow stromal cells in fibrous dysplasia. Cells. 2024;13:774.","journal-title":"Cells"},{"key":"3909_CR40","doi-asserted-by":"publisher","first-page":"e0227279","DOI":"10.1371\/journal.pone.0227279","volume":"15","author":"D Raimondo","year":"2020","unstructured":"Raimondo D, Remoli C, Astrologo L, Burla R, La Torre M, Vern\u00ec F, et al. Changes in gene expression in human skeletal stem cells transduced with constitutively active Gs\u03b1 correlates with hallmark histopathological changes seen in fibrous dysplastic bone. PLoS ONE. 2020;15:e0227279.","journal-title":"PLoS ONE"},{"key":"3909_CR41","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1359\/jbmr.091036","volume":"25","author":"S Piersanti","year":"2009","unstructured":"Piersanti S, Remoli C, Saggio I, Funari A, Michienzi S, Sacchetti B, et al. Transfer, analysis and reversion of the fibrous dysplasia cellular phenotype in human skeletal progenitors. J Bone Miner Res. 2009;25:1103\u201316.","journal-title":"J Bone Miner Res"},{"key":"3909_CR42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.biomaterials.2016.08.042","volume":"107","author":"M-O Lee","year":"2016","unstructured":"Lee M-O, You CH, Son M-Y, Kim Y-D, Jeon H, Chang J-S, et al. Pro-fibrotic effects of PFKFB4-mediated glycolytic reprogramming in fibrous dysplasia. Biomaterials. 2016;107:61\u201373.","journal-title":"Biomaterials"},{"key":"3909_CR43","doi-asserted-by":"publisher","first-page":"7526","DOI":"10.1038\/s41598-024-54655-z","volume":"14","author":"I Wallach","year":"2024","unstructured":"Wallach I, Bernard D, Nguyen K, Ho G, Morrison A, Stecula A, et al. AI is a viable alternative to high throughput screening: a 318-target study. Sci Rep. 2024;14:7526.","journal-title":"Sci Rep"},{"key":"3909_CR44","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.stemcr.2020.05.008","volume":"15","author":"S Onodera","year":"2020","unstructured":"Onodera S, Saito A, Hojo H, Nakamura T, Zujur D, Watanabe K, et al. Hedgehog activation regulates human osteoblastogenesis. Stem Cell Rep. 2020;15:125\u201339.","journal-title":"Stem Cell Rep"},{"key":"3909_CR45","doi-asserted-by":"publisher","first-page":"116679","DOI":"10.1016\/j.bone.2023.116679","volume":"169","author":"ME Meier","year":"2023","unstructured":"Meier ME, Hagelstein-Rotman M, Majoor BCJ, Geels RES, Appelman-Dijkstra NM, Bravenboer N. Expression of RANKL in breast cancer tissue in patients with fibrous dysplasia\/McCune-Albright syndrome. Bone. 2023;169:116679.","journal-title":"Bone"},{"key":"3909_CR46","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/jbmr.3602","volume":"34","author":"LF de Castro","year":"2019","unstructured":"de Castro LF, Burke AB, Wang HD, Tsai J, Florenzano P, Pan KS, et al. Activation of RANK\/RANKL\/OPG pathway is involved in the pathophysiology of fibrous dysplasia and associated with disease burden. J Bone Min Res. 2019;34:290\u20134.","journal-title":"J Bone Min Res"},{"key":"3909_CR47","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/S8756-3282(03)00064-4","volume":"33","author":"M Riminucci","year":"2003","unstructured":"Riminucci M, Kuznetsov SA, Cherman N, Corsi A, Bianco P, Robey PG. Osteoclastogenesis in fibrous dysplasia of bone: in situ and in vitro analysis of IL-6 expression. Bone. 2003;33:434\u201342.","journal-title":"Bone"},{"key":"3909_CR48","first-page":"8532","volume":"7","author":"S-H Zhou","year":"2014","unstructured":"Zhou S-H, Yang W-J, Liu S-W, Li J, Zhang C-Y, Zhu Y, et al. Gene expression profiling of craniofacial fibrous dysplasia reveals ADAMTS2 overexpression as a potential marker. Int J Clin Exp Pathol. 2014;7:8532\u201341.","journal-title":"Int J Clin Exp Pathol"},{"key":"3909_CR49","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1002\/ajmg.a.33559","volume":"152A","author":"J Kiss","year":"2010","unstructured":"Kiss J, Balla B, K\u00f3sa JP, Borsy A, Podani J, Tak\u00e1cs I, et al. Gene expression patterns in the bone tissue of women with fibrous dysplasia. Am J Med Genet A. 2010;152A:2211\u201320.","journal-title":"Am J Med Genet A"},{"key":"3909_CR50","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1556\/oh.2010.28967","volume":"151","author":"J Kiss","year":"2010","unstructured":"Kiss J, Balla B, K\u00f3sa JP, Borsy A, Podani J, Tak\u00e1cs I, et al. Changes of gene expression and its role in pathogenesis in fibrous and non-fibrous dysplastic bone tissues in women. Orv Hetil. 2010;151:1656\u201365.","journal-title":"Orv Hetil"},{"key":"3909_CR51","doi-asserted-by":"publisher","first-page":"105347","DOI":"10.1016\/j.archoralbio.2022.105347","volume":"135","author":"Z Ling","year":"2022","unstructured":"Ling Z, Xiao N, Li Y, Xie H, Xiao T, Jiang H, et al. Differential expression profiles and function prediction of tRNA-derived fragments in fibrous dysplasia. Arch Oral Biol. 2022;135:105347.","journal-title":"Arch Oral Biol"},{"key":"3909_CR52","doi-asserted-by":"publisher","first-page":"101156","DOI":"10.1016\/j.bonr.2021.101156","volume":"16","author":"A Persichetti","year":"2022","unstructured":"Persichetti A, Milanetti E, Palmisano B, di Filippo A, Spica E, Donsante S, et al. Nanostring technology on fibrous dysplasia bone biopsies. A pilot study suggesting different histology-related molecular profiles. Bone Rep. 2022;16:101156.","journal-title":"Bone Rep"},{"key":"3909_CR53","first-page":"292","volume":"38","author":"J Tang","year":"2009","unstructured":"Tang J, Zhao H, Zheng L, Zhang H, Jiang Z. [Abnormal expression of c-myc, p53, p16 protein and GNAS1 gene mutation in fibrous dysplasia]. Zhonghua Bing Li Xue Za Zhi. 2009;38:292\u20137.","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"3909_CR54","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/jop.13282","volume":"51","author":"FF Duarte-Andrade","year":"2022","unstructured":"Duarte-Andrade FF, Pereira T, dos SF, Vit\u00f3rio JG, Diniz MG, Amorim LSD, Nawrocki A, et al. Quantitative proteomic study reveals differential expression of matricellular proteins between fibrous dysplasia and cemento\u2010ossifying fibroma pathogenesis. J Oral Pathol Med. 2022;51:405\u201312.","journal-title":"J Oral Pathol Med"},{"key":"3909_CR55","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3390\/cells13090729","volume":"13","author":"H-Y Kim","year":"2024","unstructured":"Kim H-Y, Charton C, Shim JH, Lim SY, Kim J, Lee S, et al. Patient-Derived organoids recapitulate pathological intrinsic and phenotypic features of fibrous dysplasia. Cells. 2024;13:729.","journal-title":"Cells"},{"key":"3909_CR56","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jormas.2021.04.008","volume":"123","author":"M Soluk-Tekkesin","year":"2022","unstructured":"Soluk-Tekkesin M, Sinanoglu A, Selvi F, Cakir Karabas H, Aksakalli N. The importance of clinical and radiological findings for the definitive histopathologic diagnosis of benign fibro-osseous lesions of the jaws: study of 276 cases. J Stomatol Oral Maxillofac Surg. 2022;123:364\u201371.","journal-title":"J Stomatol Oral Maxillofac Surg"},{"key":"3909_CR57","doi-asserted-by":"publisher","first-page":"7519","DOI":"10.1007\/s00500-021-06519-1","volume":"26","author":"A Saranya","year":"2022","unstructured":"Saranya A, Kottursamy K, AlZubi AA, Bashir AK. Analyzing fibrous tissue pattern in fibrous dysplasia bone images using deep R-CNN networks for segmentation. Soft Comput. 2022;26:7519\u201333.","journal-title":"Soft Comput"},{"key":"3909_CR58","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/jbmr.4766","volume":"38","author":"KL Roszko","year":"2023","unstructured":"Roszko KL, Guthrie L, Li X, Collins MT, de Castro LF, Boyce AM. Identification of <\u2009scp\u2009>GNAS \u2009variants in Circulating\u2009<\u2009scp\u2009>\u2009Cell-Free dna\u2009from patients with fibrous dysplasia\/ <scp\u2009>\u2009mccune\u2009albright syndrome<\/scp\u2009>. J Bone Miner Res. 2023;38:443\u201350.","journal-title":"J Bone Miner Res"},{"key":"3909_CR59","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s12105-024-01634-5","volume":"18","author":"GG Zhu","year":"2024","unstructured":"Zhu GG, Lu C, Petrovic I, Nafa K, Chen W, Syed A, et al. DNA mutational and copy number variation profiling of primary craniofacial osteosarcomas by Next-Generation sequencing. Head Neck Pathol. 2024;18:48.","journal-title":"Head Neck Pathol"},{"key":"3909_CR60","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/jop.13384","volume":"52","author":"K Jia","year":"2023","unstructured":"Jia K, Zhang J, Li T, Zhang Y, An J. Comparison of the histopathological characteristics of diffuse sclerosing osteomyelitis of the mandible, chronic suppurative osteomyelitis, and craniofacial fibrous dysplasia. J Oral Pathol Med. 2023;52:91\u20138.","journal-title":"J Oral Pathol Med"},{"key":"3909_CR61","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41379-022-01103-w","volume":"35","author":"J Xue","year":"2022","unstructured":"Xue J, Jia K, Li T, Zhang J, An J. GNAS mutation analysis assists in differentiating chronic diffuse sclerosing osteomyelitis from fibrous dysplasia in the jaw. Mod Pathol. 2022;35:1334\u201340.","journal-title":"Mod Pathol"},{"key":"3909_CR62","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41368-021-00127-3","volume":"13","author":"M Ma","year":"2021","unstructured":"Ma M, Liu L, Shi R, Zhang J, Li X, Li X, et al. Copy number alteration profiling facilitates differential diagnosis between ossifying fibroma and fibrous dysplasia of the jaws. Int J Oral Sci. 2021;13:21.","journal-title":"Int J Oral Sci"},{"key":"3909_CR63","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1210\/clinem\/dgab053","volume":"106","author":"M Zhadina","year":"2021","unstructured":"Zhadina M, Roszko KL, Geels RES, de Castro LF, Collins MT, Boyce AM. Genotype-Phenotype correlation in fibrous Dysplasia\/McCune-Albright syndrome. J Clin Endocrinol Metab. 2021;106:1482\u201390.","journal-title":"J Clin Endocrinol Metab"},{"key":"3909_CR64","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1097\/00007890-199704270-00003","volume":"63","author":"PH Krebsbach","year":"1997","unstructured":"Krebsbach PH, Kuznetsov SA, Satomura K, Emmons RVB, Rowe DW, Robey PG. Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation. 1997;63:1059\u201369.","journal-title":"Transplantation"},{"key":"3909_CR65","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3109\/17453679008993556","volume":"61","author":"H Ohgushi","year":"1990","unstructured":"Ohgushi H, Okumura M. Osteogenic capacity of rat and human marrow cells in porous ceramics: experiments in athymic (nude) mice. Acta Orthop Scand. 1990;61:431\u20134.","journal-title":"Acta Orthop Scand"},{"key":"3909_CR66","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1083\/jcb.200408079","volume":"167","author":"SA Kuznetsov","year":"2004","unstructured":"Kuznetsov SA, Riminucci M, Ziran N, Tsutsui TW, Corsi A, Calvi L, et al. The interplay of osteogenesis and hematopoiesis. J Cell Biol. 2004;167:1113\u201322.","journal-title":"J Cell Biol"},{"key":"3909_CR67","doi-asserted-by":"crossref","unstructured":"Hsiao EC, Boudignon BM, Chang WC, Bencsik M, Peng J, Nguyen TD et al. Osteoblast expression of an engineered G s -coupled receptor dramatically increases bone mass. Proceedings of the National Academy of Sciences. 2008;105:1209\u201314.","DOI":"10.1073\/pnas.0707457105"},{"key":"3909_CR68","doi-asserted-by":"crossref","unstructured":"Regard JB, Cherman N, Palmer D, Kuznetsov SA, Celi FS, Guettier J-M et al. Wnt\/\u03b2-catenin signaling is differentially regulated by G\u03b1 proteins and contributes to fibrous dysplasia. Proceedings of the National Academy of Sciences. 2011;108:20101\u20136.","DOI":"10.1073\/pnas.1114656108"},{"key":"3909_CR69","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/35093537","volume":"2","author":"M Lewandoski","year":"2001","unstructured":"Lewandoski M. Conditional control of gene expression in the mouse. Nat Rev Genet. 2001;2:743\u201355.","journal-title":"Nat Rev Genet"},{"key":"3909_CR70","doi-asserted-by":"crossref","unstructured":"Zhao X, Deng P, Iglesias-Bartolome R, Amornphimoltham P, Steffen DJ, Jin Y et al. Expression of an active G\u03b1 s mutant in skeletal stem cells is sufficient and necessary for fibrous dysplasia initiation and maintenance. Proceedings of the National Academy of Sciences. 2018;115.","DOI":"10.1073\/pnas.1713710115"},{"key":"3909_CR71","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41413-018-0034-7","volume":"6","author":"R Xu","year":"2018","unstructured":"Xu R, Khan SK, Zhou T, Gao B, Zhou Y, Zhou X, et al. G\u03b1s signaling controls intramembranous ossification during cranial bone development by regulating both Hedgehog and Wnt\/\u03b2-catenin signaling. Bone Res. 2018;6:33.","journal-title":"Bone Res"},{"key":"3909_CR72","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1002\/jbmr.2425","volume":"30","author":"C Remoli","year":"2015","unstructured":"Remoli C, Michienzi S, Sacchetti B, Consiglio A, Di, Cersosimo S, Spica E, et al. Osteoblast-Specific Expression of the Fibrous Dysplasia (FD)-Causing Mutation Gs\u03b1 R201C Produces a High Bone Mass Phenotype but Does Not Reproduce FD in the Mouse. J Bone Miner Res. 2015;30:1030\u201343.","journal-title":"J Bone Miner Res"},{"key":"3909_CR73","doi-asserted-by":"publisher","first-page":"116270","DOI":"10.1016\/j.bone.2021.116270","volume":"155","author":"C Hopkins","year":"2022","unstructured":"Hopkins C, de Castro LF, Corsi A, Boyce A, Collins MT, Riminucci M, et al. Fibrous dysplasia animal models: A systematic review. Bone. 2022;155:116270.","journal-title":"Bone"},{"key":"3909_CR74","doi-asserted-by":"crossref","unstructured":"Lung H, Hsiao EC, Wentworth KL. Advances in models of fibrous Dysplasia\/McCune-Albright syndrome. Front Endocrinol (Lausanne). 2020;10.","DOI":"10.3389\/fendo.2019.00925"},{"key":"3909_CR75","doi-asserted-by":"publisher","first-page":"116301","DOI":"10.1016\/j.bone.2021.116301","volume":"156","author":"Z Liu","year":"2022","unstructured":"Liu Z, Yin Y, Wang Z, Xie L, Deng P, Wang D, et al. RANKL Inhibition halts lesion progression and promotes bone remineralization in mice with fibrous dysplasia. Bone. 2022;156:116301.","journal-title":"Bone"},{"key":"3909_CR76","doi-asserted-by":"crossref","unstructured":"Cong Q, Liu Y, Zhou T, Zhou Y, Xu R, Cheng C et al. A self-amplifying loop of YAP and SHH drives formation and expansion of heterotopic ossification. Sci Transl Med. 2021;13.","DOI":"10.1126\/scitranslmed.abb2233"},{"key":"3909_CR77","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/nm.3314","volume":"19","author":"JB Regard","year":"2013","unstructured":"Regard JB, Malhotra D, Gvozdenovic-Jeremic J, Josey M, Chen M, Weinstein LS, et al. Activation of Hedgehog signaling by loss of GNAS causes heterotopic ossification. Nat Med. 2013;19:1505\u201312.","journal-title":"Nat Med"},{"key":"3909_CR78","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/1750-1172-7-S1-S3","volume":"7","author":"RD Chapurlat","year":"2012","unstructured":"Chapurlat RD, Gensburger D, Jimenez-Andrade JM, Ghilardi JR, Kelly M, Mantyh P. Pathophysiology and medical treatment of pain in fibrous dysplasia of bone. Orphanet J Rare Dis. 2012;7:S3.","journal-title":"Orphanet J Rare Dis"},{"key":"3909_CR79","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00198-007-0425-x","volume":"19","author":"MH Kelly","year":"2008","unstructured":"Kelly MH, Brillante B, Collins MT. Pain in fibrous dysplasia of bone: age-related changes and the anatomical distribution of skeletal lesions. Osteoporos Int. 2008;19:57\u201363.","journal-title":"Osteoporos Int"},{"key":"3909_CR80","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/17453674.2019.1608117","volume":"90","author":"BCJ Majoor","year":"2019","unstructured":"Majoor BCJ, Traunmueller E, Maurer-Ertl W, Appelman-Dijkstra NM, Fink A, Liegl B, et al. Pain in fibrous dysplasia: relationship with anatomical and clinical features. Acta Orthop. 2019;90:401\u20135.","journal-title":"Acta Orthop"},{"key":"3909_CR81","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.anorl.2017.02.004","volume":"134","author":"A Couturier","year":"2017","unstructured":"Couturier A, Auma\u00eetre O, Gilain L, Jean B, Mom T, Andr\u00e9 M. Craniofacial fibrous dysplasia: A 10-case series. Eur Ann Otorhinolaryngol Head Neck Dis. 2017;134:229\u201335.","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"3909_CR82","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/lary.25078","volume":"125","author":"CD Frisch","year":"2015","unstructured":"Frisch CD, Carlson ML, Kahue CN, Pelosi S, Haynes DS, Lane JI, et al. Fibrous dysplasia of the Temporal bone: A review of 66 cases. Laryngoscope. 2015;125:1438\u201343.","journal-title":"Laryngoscope"},{"key":"3909_CR83","doi-asserted-by":"publisher","first-page":"e417","DOI":"10.1097\/SCS.0000000000002685","volume":"27","author":"KS Kim","year":"2016","unstructured":"Kim KS. Headache attributed to fibrous dysplasia of the ethmoid bone mimicking menstrual migraine without aura. J Craniofac Surg. 2016;27:e417\u20139.","journal-title":"J Craniofac Surg"},{"key":"3909_CR84","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1302\/0301-620X.97B7.35828","volume":"97\u2013B","author":"H-S Kim","year":"2015","unstructured":"Kim H-S, Im SB, Han I. Osteoarthritis of the hip in fibrous dysplasia of the proximal femur. Bone Joint J. 2015;97\u2013B:1007\u201311.","journal-title":"Bone Joint J"},{"key":"3909_CR85","doi-asserted-by":"publisher","first-page":"e2258","DOI":"10.1210\/clinem\/dgac120","volume":"107","author":"TL Spencer","year":"2022","unstructured":"Spencer TL, Watts L, Soni A, Pinedo-Villanueva R, Heegaard A-M, Boyce AM, et al. Neuropathic-like pain in fibrous Dysplasia\/McCune-Albright syndrome. J Clin Endocrinol Metab. 2022;107:e2258\u201366.","journal-title":"J Clin Endocrinol Metab"},{"key":"3909_CR86","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1210\/clinem\/dgad589","volume":"109","author":"E van der Golden","year":"2024","unstructured":"van der Golden E, Ren B, Randall ET, Drubach LA, Shah N, et al. Phenotyping pain in patients with fibrous Dysplasia\/McCune-Albright syndrome. J Clin Endocrinol Metab. 2024;109:771\u201382.","journal-title":"J Clin Endocrinol Metab"},{"key":"3909_CR87","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/jbmr.3649","volume":"34","author":"P Florenzano","year":"2019","unstructured":"Florenzano P, Pan KS, Brown SM, Paul SM, Kushner H, Guthrie LC, et al. Age-Related changes and effects of bisphosphonates on bone turnover and disease progression in fibrous dysplasia of bone. J Bone Miner Res. 2019;34:653\u201360.","journal-title":"J Bone Miner Res"},{"key":"3909_CR88","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.neubiorev.2021.02.009","volume":"124","author":"A Tucker-Bartley","year":"2021","unstructured":"Tucker-Bartley A, Lemme J, Gomez-Morad A, Shah N, Veliu M, Birklein F, et al. Pain phenotypes in rare musculoskeletal and neuromuscular diseases. Neurosci Biobehav Rev. 2021;124:267\u201390.","journal-title":"Neurosci Biobehav Rev"},{"key":"3909_CR89","doi-asserted-by":"publisher","first-page":"115784","DOI":"10.1016\/j.bone.2020.115784","volume":"143","author":"R Chapurlat","year":"2021","unstructured":"Chapurlat R, Legrand MA. Bisphosphonates for the treatment of fibrous dysplasia of bone. Bone. 2021;143:115784.","journal-title":"Bone"},{"key":"3909_CR90","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1210\/jc.2014-1371","volume":"99","author":"AM Boyce","year":"2014","unstructured":"Boyce AM, Kelly MH, Brillante BA, Kushner H, Wientroub S, Riminucci M, et al. A randomized, double blind, Placebo-Controlled trial of alendronate treatment for fibrous dysplasia of bone. J Clin Endocrinol Metab. 2014;99:4133\u201340.","journal-title":"J Clin Endocrinol Metab"},{"key":"3909_CR91","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/jbmr.2999","volume":"32","author":"BC Majoor","year":"2017","unstructured":"Majoor BC, Appelman-Dijkstra NM, Fiocco M, van de Sande MA, Dijkstra PS, Hamdy NA. Outcome of Long-Term bisphosphonate therapy in McCune-Albright syndrome and polyostotic fibrous dysplasia. J Bone Miner Res. 2017;32:264\u201376.","journal-title":"J Bone Miner Res"},{"key":"3909_CR92","doi-asserted-by":"crossref","unstructured":"Hopkins C, de Castro LF, Benthin J, Diaz-delCastillo M, Manjappa P, Boyce A et al. Pain in fibrous dysplasia: identifying nociceptive mechanisms in a preclinical model. J Bone Min Res. 2025.","DOI":"10.1093\/jbmr\/zjaf039"},{"key":"3909_CR93","doi-asserted-by":"crossref","unstructured":"Finno CJ, Chen Y, Park S, Lee JH, Perez-Flores MC, Choi J et al. Cisplatin neurotoxicity targets specific subpopulations and K + Channels in Tyrosine-Hydroxylase positive dorsal root ganglia neurons. Front Cell Neurosci. 2022;16.","DOI":"10.3389\/fncel.2022.853035"},{"key":"3909_CR94","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/j.pain.0000000000000381","volume":"157","author":"PR Brumovsky","year":"2016","unstructured":"Brumovsky PR. Dorsal root ganglion neurons and tyrosine hydroxylase\u2014an intriguing association with implications for sensation and pain. Pain. 2016;157:314\u201320.","journal-title":"Pain"},{"key":"3909_CR95","doi-asserted-by":"crossref","unstructured":"Palmisano B, Tavanti C, Farinacci G, Gosti G, Leonetti M, Donsante S et al. Bone pain in fibrous dysplasia does not rely on aberrant sensory nerve sprouting or neuroma formation. J Bone Miner Res. 2025.","DOI":"10.1101\/2024.07.18.603554"},{"key":"3909_CR96","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1210\/jc.2006-2350","volume":"92","author":"P Feuillan","year":"2007","unstructured":"Feuillan P, Calis K, Hill S, Shawker T, Robey PG, Collins MT. Letrozole treatment of precocious puberty in girls with the McCune-Albright syndrome: A pilot study. J Clin Endocrinol Metab. 2007;92:2100\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"3909_CR97","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1056\/NEJM198610303151802","volume":"315","author":"PP Feuillan","year":"1986","unstructured":"Feuillan PP, Foster CM, Pescovitz OH, Hench KD, Shawker T, Dwyer A, et al. Treatment of precocious puberty in the McCune\u2013Albright syndrome with the aromatase inhibitor testolactone. N Engl J Med. 1986;315:1115\u20139.","journal-title":"N Engl J Med"},{"key":"3909_CR98","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1530\/EJE-16-0526","volume":"175","author":"A Estrada","year":"2016","unstructured":"Estrada A, Boyce AM, Brillante BA, Guthrie LC, Gafni RI, Collins MT. Long-term outcomes of letrozole treatment for precocious puberty in girls with McCune\u2013Albright syndrome. Eur J Endocrinol. 2016;175:477\u201383.","journal-title":"Eur J Endocrinol"},{"key":"3909_CR99","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0022-3476(03)00128-8","volume":"143","author":"EA Eugster","year":"2003","unstructured":"Eugster EA, Rubin SD, Reiter EO, Plourde P, Jou H-C, Pescovitz OH. Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial. J Pediatr. 2003;143:60\u20136.","journal-title":"J Pediatr"},{"key":"3909_CR100","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1687-9856-2012-26","volume":"2012","author":"EK Sims","year":"2012","unstructured":"Sims EK, Garnett S, Guzman F, Paris F, Sultan C, Eugster EA. Fulvestrant treatment of precocious puberty in girls with McCune-Albright syndrome. Int J Pediatr Endocrinol. 2012;2012:26.","journal-title":"Int J Pediatr Endocrinol"},{"key":"3909_CR101","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000342641","volume":"78","author":"D Tessaris","year":"2012","unstructured":"Tessaris D, Corrias A, Matarazzo P, De Sanctis L, Wasniewska M, Messina MF, et al. Thyroid abnormalities in children and adolescents with McCune-Albright syndrome. Horm Res Paediatr. 2012;78:151\u20137.","journal-title":"Horm Res Paediatr"},{"key":"3909_CR102","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1210\/jc.2009-2321","volume":"95","author":"RJ Brown","year":"2010","unstructured":"Brown RJ, Kelly MH, Collins MT. Cushing syndrome in the McCune-Albright syndrome. J Clin Endocrinol Metab. 2010;95:1508\u201315.","journal-title":"J Clin Endocrinol Metab"},{"key":"3909_CR103","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1359\/jbmr.2001.16.5.806","volume":"16","author":"MT Collins","year":"2001","unstructured":"Collins MT, Chebli C, Jones J, Kushner H, Consugar M, Rinaldo P, et al. Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in Tumor-Induced osteomalacia. J Bone Miner Res. 2001;16:806\u201313.","journal-title":"J Bone Miner Res"},{"key":"3909_CR104","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1172\/JCI18399","volume":"112","author":"M Riminucci","year":"2003","unstructured":"Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE, et al. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest. 2003;112:683\u201392.","journal-title":"J Clin Invest"},{"key":"3909_CR105","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jmb.2006.07.045","volume":"362","author":"M Kamenetsky","year":"2006","unstructured":"Kamenetsky M, Middelhaufe S, Bank EM, Levin LR, Buck J, Steegborn C. Molecular details of cAMP generation in mammalian cells: A Tale of two systems. J Mol Biol. 2006;362:623\u201339.","journal-title":"J Mol Biol"},{"key":"3909_CR106","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1124\/pr.116.013078","volume":"69","author":"CW Dessauer","year":"2017","unstructured":"Dessauer CW, Watts VJ, Ostrom RS, Conti M, Dove S, Seifert R. International union of basic and clinical pharmacology. CI. Structures and small molecule modulators of mammalian adenylyl cyclases. Pharmacol Rev. 2017;69:93\u2013139.","journal-title":"Pharmacol Rev"},{"key":"3909_CR107","doi-asserted-by":"publisher","first-page":"3950","DOI":"10.1016\/j.cell.2022.09.019","volume":"185","author":"SA Dai","year":"2022","unstructured":"Dai SA, Hu Q, Gao R, Blythe EE, Touhara KK, Peacock H, et al. State-selective modulation of heterotrimeric G\u03b1s signaling with macrocyclic peptides. Cell. 2022;185:3950\u2013e396525.","journal-title":"Cell"},{"key":"3909_CR108","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.ejmech.2018.11.036","volume":"162","author":"J Kaur","year":"2019","unstructured":"Kaur J, Soto-Velasquez M, Ding Z, Ghanbarpour A, Lill MA, van Rijn RM, et al. Optimization of a 1,3,4-oxadiazole series for Inhibition of Ca2+\/calmodulin-stimulated activity of adenylyl cyclases 1 and 8 for the treatment of chronic pain. Eur J Med Chem. 2019;162:568\u201385.","journal-title":"Eur J Med Chem"},{"key":"3909_CR109","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.cellsig.2019.04.010","volume":"60","author":"RA Getz","year":"2019","unstructured":"Getz RA, Kwak G, Cornell S, Mbugua S, Eberhard J, Huang SX, et al. A fission yeast platform for heterologous expression of mammalian adenylyl cyclases and high throughput screening. Cell Signal. 2019;60:114\u201321.","journal-title":"Cell Signal"},{"key":"3909_CR110","doi-asserted-by":"crossref","unstructured":"Wang H, Xu H, Wu L-J, Kim SS, Chen T, Koga K et al. Identification of an adenylyl cyclase inhibitor for treating neuropathic and inflammatory pain. Sci Transl Med. 2011;3.","DOI":"10.1126\/scitranslmed.3001269"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03909-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03909-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03909-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T19:47:10Z","timestamp":1757360830000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03909-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":110,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3909"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03909-8","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JFC has received grant support from Novartis and honoraria from Abbvie, Alexion, Ultragenyx, and Kyowa Kirin. ECH serves in an unpaid capacity on the Medical Registry Advisory Board of the International Fibrodysplasia Ossificans Progressiva Association (FOP); the Fibrous Dysplasia Foundation Medical Advisory Board and Scientific Advisory Board; and the International Clinical Council on FOP. ECH receives clinical trials support through his institution from Clementia Pharmaceuticals, an Ipsen Company; Ipsen Pharmaceuticals; Ascendis Bio, and ashibio.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"414"}}